Comprehensive in-lab NIPT IVD solution including reagents, instruments, and software for accurate aneuploidy screening results in 26 hours.
This product is only available in select locations. Please select the location where you would like this product to be shipped to see availability.
Veriseq NIPT v2 is a streamlined, accessible NIPT solution that provides clinicians with results they can trust.
Broad test menu expands prenatal screening beyond aneuploidies 21, 18, and 13 to all rare autosomal aneuploidies (RAAs), sex chromosome aneuploidies (SCAs) and partial duplications and deletions ≥ 7 Mb for all autosomes. As a result, VeriSeq NIPT v2 detects anomalies that targeted assays miss to deliver more insights into the health of a pregnancy.
VeriSeq NIPT v2 offers a simple, scalable IVD solution that can analyze 24, 48, or 96 samples per run. Sample preparation is automated on the VeriSeq NIPT Microlab STAR system from Hamilton Robotics.
VeriSeq NIPT v2 is an extensively validated NIPT with a low test failure rate (1.2%) and high concordance with clinical reference data. 1
The VeriSeq NIPT Solution v2 is an in vitro diagnostic test intended for use as a screening test for the detection of genome-wide fetal genetic anomalies from maternal peripheral whole blood specimens in pregnant women of at least 10 weeks gestation. VeriSeq NIPT Solution v2 uses whole-genome sequencing to detect partial duplications and deletions for all autosomes and aneuploidy status for all chromosomes. The test offers an option to request the reporting of sex chromosome aneuploidy (SCA). This product must not be used as the sole basis for diagnosis or other pregnancy management decisions. The VeriSeq NIPT Solution v2 includes: the VeriSeq NIPT Workflow Manager v2 for the VeriSeq NIPT Microlab STAR, the VeriSeq NIPT Sample Prep Kits, and the VeriSeq Onsite Server v2 with the VeriSeq NIPT Assay Software v2. The VeriSeq NIPT Solution v2 is intended to be used with a next-generation sequencer.
For In Vitro Diagnostic Use
Contact an Illumina representative for regional availability.
| Instruments | NextSeq 550Dx Instrument |
|---|---|
| Method | NIPT sequencing, Whole-genome sequencing |
| Nucleic acid type | DNA |
| Species category | Human |
| Technology | Sequencing |
These sequencing reagent kits offer a simplified workflow and high data quality for in vitro diagnostic testing on the NextSeq550 Dx Instrument.
Comprehensive in-lab NIPT IVD solution including reagents, instruments, and software for accurate aneuploidy screening results in 26 hours.
A library preparation and enrichment solution for IVD targeted sequencing applications.
References
Reach out for information about our products and services, or get answers to questions about our technology.
Your email address is never shared with third parties.
